Healthtech Startups

Opt Health connects patients with medical experts for personalized consultations via telemedicine, providing preventive care guidance and treatment plans delivered online and through an integrated pharmacy service.

3 investors

Optellum builds an AI-powered platform for early lung cancer diagnosis, helping thoracic care teams and health systems discover, track, and assess the malignancy risk of lung nodule patients. Its technology integrates with hospital EHR and PACS systems and uses deep learning models trained on large chest CT datasets.

3 investors

Optimeos develops a nanoparticle-based drug formulation and delivery platform (CINCs and LINCs) for complex biologics including mRNA, DNA, peptides, and proteins, targeting rare diseases, immunology, and metabolic conditions such as obesity. Its technology enables intracellular and long-acting delivery for pharmaceutical and biotech partners addressing challenges like tissue targeting and dosing profiles.

3 investors

Dowds is a UK-based engineering company providing integrated technical solutions and design-led project delivery for complex built environments, with particular expertise in healthcare infrastructure, mechanical, electrical, and building systems integration.

3 investors

Optura helps enterprise healthcare organizations identify and implement AI initiatives with measurable returns on investment. The company provides a platform and methodology for aligning executives, evaluating AI pilots, deploying technology interventions, and tracking performance across healthcare workflows and systems.

3 investors

ORA is a digital health and wellness company offering telehealth and hybrid (virtual and in-person) consultations for chronic conditions, weight management, reproductive health, and aesthetics. It operates consumer brands andSons (men's health), OVA (women's health), and Modern Molecules (anti-ageing), serving patients primarily in Singapore.

3 investors

Orakl Oncology, a spin-off from Gustave Roussy, builds an AI-and-biology platform that grows patient-derived tumor organoids and enriches them with genomic, transcriptomic, phenotypic, and clinical data to predict drug response and clinical trial outcomes. It offers O-Predict for anticipating clinical endpoints and biomarkers and O-Target for therapeutic target discovery, serving biopharma companies in oncology drug discovery and development.

3 investors

A pharmaceutical company developing therapeutics across oncology, hematology, neuroscience, immunology, and cardiovascular disease with a pipeline of 50 compounds targeting 40+ disease areas.

3 investors

Orbital RX provides a software platform for hospital pharmacy supply chain management that integrates inventory tracking, procurement workflows, and real-time team collaboration to coordinate shortage response across healthcare networks.

3 investors

Orbus Therapeutics is a clinical-stage biopharmaceutical company developing eflornithine (DFMO), an oral ODC inhibitor, as a cancer therapy. Its lead candidate targets recurrent grade 3 IDH-mutant astrocytoma and other cancers with ODC overexpression.

3 investors

OrganoidSciences develops organoid-based regenerative therapeutics and evaluation solutions, operating dedicated GMP manufacturing facilities for cell/organoid drug production. Its lead program ATORM-C is an organoid therapy for inflammatory bowel disease, with clinical development across Korea, the US, and Europe.

3 investors

Oricell Therapeutics (原启生物) is a clinical-stage biopharmaceutical company developing cell therapies, including CAR-T products targeting GPRC5D for relapsed/refractory multiple myeloma and GPC3 for advanced liver cancer. Based in Shanghai, it builds proprietary antibody and CAR platforms (OriAb, OriCAR) to create cancer immunotherapies for unmet oncology needs such as liver, gastric, pancreatic, biliary, and ovarian cancers.

3 investors

Origin provides pelvic floor physical therapy for women and individuals with vaginal anatomy through in-clinic and virtual care. The company operates 20 clinics across the U.S. and delivers specialized treatment for conditions like postpartum recovery, menopause, and pelvic pain.

3 investors

Origin provides in-home pediatric speech, occupational, and physical therapy, connecting families with local licensed therapists and offering insurance-covered sessions. The company also serves therapists by letting them set their own schedules, choose clients, and build flexible caseloads.

3 investors

OrthAlign develops medical device technology for precise alignment during hip and knee replacement surgery, serving orthopedic surgeons in the surgical technology space.

3 investors

OrthoFX makes AirFlex, an FDA-cleared clear aligner system that straightens teeth with at least 12 hours of continuous daily wear using a patented elastic polymer for lower force. The company also offers patient financing and provides its aligner products through dental and orthodontic providers.

3 investors

Unable to determine from the page provided. The team page contains only a biographical entry for a pain management physician without company background or product information.

3 investors

OS Benefits provides affordable health insurance and wellness benefits designed specifically for the hospitality industry, targeting independent restaurant and hospitality business owners seeking to provide employee healthcare coverage at sustainable costs.

3 investors

Osara Health (formerly CancerAid) provides evidence-based education, support and behavior-change programs for people impacted by cancer, including patients and caregivers, with the aim of improving clinical outcomes such as quality of life, physical and mental health, and survival rates. Founded in 2016 by oncologists, it operates as a global organization with Australian roots.

3 investors

Osigu provides an API-based platform serving the healthcare sector across Latin America and the US. The page offers limited detail beyond its developer API and office locations.

3 investors

OSSTEC is a medical device startup developing a 3D-printed biomimetic knee implant intended for use in hospitals. Founded out of Imperial College London, the company focuses on orthopedic implants aimed at improving patient mobility and quality of life.

3 investors

Otomo Health builds AI voice technology based on large language models to support medical offices, providers, and patients across the care journey. The company focuses on healthcare applications that ease workload for medical professionals and improve the patient experience.

3 investors

Advocate uses AI-assisted technology and a team of disability advocates to help individuals apply for and secure Social Security Disability Insurance (SSDI) benefits. It also works with long-term disability carriers and organizations on SSDI claim processes.

3 investors

Ouro Medicines is a biotechnology company developing cell-depleting therapies aimed at resetting the immune system to treat chronic immune-mediated diseases such as autoimmune and autoinflammatory conditions. It is advancing a pipeline of biologics and small molecules across immunology and related therapeutic areas.

3 investors